Shanghai PerHum Therapeutics Co., Ltd.

Works in Dermatology · GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Women's health

Shanghai PerHum Therapeutics Co., Ltd. is a clinical trial sponsor. It has 1 active clinical trial with 12 planned participants, across 6 therapeutic areas. Since 2021 it has completed 0 trials and stopped 3 early.

Trial track record · since 2021

1Active trials12 planned participants
0Completed0 with results posted
3Stopped earlyterminated, withdrawn or suspended

Pipeline · 1 active trial

StageTrialStatus

Questions about Shanghai PerHum Therapeutics Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-10-28.

Approve Suite is not affiliated with Shanghai PerHum Therapeutics Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.